We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Direct Blood Dry LAMP Diagnoses African Trypanosomiasis

By LabMedica International staff writers
Posted on 08 Apr 2015
Loop-mediated isothermal amplification (LAMP) is a rapid and sensitive tool used for the diagnosis of a variety of infectious diseases, but still requires complicated sample preparation steps and a well-equipped laboratory to produce reliable and reproducible results. More...


Several substantial modifications to the LAMP technique have been made to carry out on-site diagnosis of Human African Trypanosomiasis (HAT) in remote areas where there are normally resource-poor laboratories in most developing countries.

Scientists at the Hokkaido University (Sapporo, Japan) working with colleagues in Zambia, refined an existing LAMP system for HAT diagnosis that is cost effective and stable at high temperature. In their system, lysed blood can be used directly with high detection sensitivity. This dry LAMP system will be widely applicable in the field or for bedside diagnosis even in areas lacking adequate infrastructure.

The first essential improvement was that LAMP reagents were dried and stabilized in a single tube by incorporating trehalose as a cryoprotectant to prolong shelf life at ambient temperature. The second technical improvement was achieved by simplifying the sample preparation step so that DNA or ribonucleic acid (RNA) could be amplified directly from detergent-lysed blood samples. Primer sets were evaluated by real-time LAMP and also melting curve analysis using the Rotor-Gene 3000 thermal cycler (Corbett Research, Sydney, Australia) to monitor the reaction, and optimal amplification time and temperature for primer sets were determined.

The investigators developed a combination of dyes that they have called a “colori-fluorometric indicator (CFI) for the LAMP reaction. They also developed a battery-driven hand-made light emitting diodes (LED) illuminator that emits 500 nm wavelength light, which was suitable for field or bedside use. Using CFI, the LAMP reactions could be detected in two ways: either by detecting amplified DNA products with GelGreen or by a decreased Magnesium (Mg2+) concentration with hydroxyl-naphtol blue (HNB). The resulting fluorescence was visible under a blue-green LED illuminator. The color of HNB changed from violet to blue during the progression of the LAMP reaction as the Mg2+ ion concentration decreased by forming insoluble magnesium pyrophosphate. These color changes were easily visible by the naked eye. The sensitivity, as determined by a ten-fold detection limit was comparable to that of calcein, a commonly used color-development reagent for LAMP.

The authors concluded that they had refined the HAT LAMP detection system, making the feasibility of LAMP for bedside diagnosis and field surveillance. Their LAMP system can be applied to a wide range of other infectious diseases and therefore paves the way for possible utilization of rapid molecular diagnostic tests at point of care stations in resource poor countries. Human African trypanosomiasis (HAT) is an endemic protozoan disease affecting many African countries, predominantly in rural areas where the tsetse fly vector is present. The study was published on March 13, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Hokkaido University 
Corbett Research 



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test
New
Pipet Controller
Stripettor Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.